Found: 146
Select item for more details and to access through your institution.
Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series.
- Published in:
- Neurological Sciences, 2023, v. 44, n. 9, p. 3291, doi. 10.1007/s10072-023-06841-6
- By:
- Publication type:
- Article
Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31015-x
- By:
- Publication type:
- Article
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0815-5
- By:
- Publication type:
- Article
Proteasome Inhibitors as a Possible Therapy for SARS-CoV-2.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3622, doi. 10.3390/ijms21103622
- By:
- Publication type:
- Article
Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 9, p. 22811, doi. 10.3390/ijms160922811
- By:
- Publication type:
- Article
Fatal ongoing human cytomegalovirus reactivation during high-dose melphalan and autologous stem cell transplantation.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 5, p. 857, doi. 10.1002/jmv.21440
- By:
- Publication type:
- Article
Personal history and quality of life in chronic myeloid leukemia patients: a cross-sectional study using narrative medicine and quantitative analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Real-life diagnostic and therapeutic approach to CLL: a 2022 update from an expert panel in Tuscany.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 8, p. 4251, doi. 10.1007/s10238-023-01244-5
- By:
- Publication type:
- Article
Induction of neutralizing antibodies in CLL patients after SARS-CoV-2 mRNA vaccination: a monocentric experience.
- Published in:
- Clinical & Experimental Medicine, 2023, v. 23, n. 4, p. 1197, doi. 10.1007/s10238-022-00877-2
- By:
- Publication type:
- Article
Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 12, p. 3865, doi. 10.3390/jcm9123865
- By:
- Publication type:
- Article
A Retrospective Analysis about Frequency of Monitoring in Italian Chronic Myeloid Leukemia Patients after Discontinuation.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 11, p. 3692, doi. 10.3390/jcm9113692
- By:
- Publication type:
- Article
Organ Stiffness in the Work-Up of Myelofibrosis and Philadelphia-Negative Chronic Myeloproliferative Neoplasms.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2149, doi. 10.3390/jcm9072149
- By:
- Publication type:
- Article
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.
- Published in:
- Stem Cells Translational Medicine, 2018, v. 7, n. 3, p. 305, doi. 10.1002/sctm.17-0175
- By:
- Publication type:
- Article
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1369601
- By:
- Publication type:
- Article
Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1369601
- By:
- Publication type:
- Article
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1367393
- By:
- Publication type:
- Article
Impact of different chemotherapy regimens on intestinal mucosal injury assessed with bedside ultrasound: a study in 213 AML patients.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1272072
- By:
- Publication type:
- Article
Editorial: Measurable residual disease in hematologic malignancies.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1204393
- By:
- Publication type:
- Article
The third dose of mRNA SARS-CoV-2 vaccines enhances the spike-specific antibody and memory B cell response in myelofibrosis patients.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.1017863
- By:
- Publication type:
- Article
Joint Pain and Arthritis as First Clinical Manifestation of Systemic Amyloidosis and Multiple Myeloma: Case Report and Brief Literature Review.
- Published in:
- Hematology Reports, 2022, v. 14, n. 1, p. 19, doi. 10.3390/hematolrep14010004
- By:
- Publication type:
- Article
Different types of amyloid concomitantly present in the same patients.
- Published in:
- Hematology Reports, 2019, v. 11, n. 4, p. 84, doi. 10.4081/hr.2019.7996
- By:
- Publication type:
- Article
PRDI-BF1 and PRDI-BF1β isoform expressions correlate with disease status in multiple myeloma patients.
- Published in:
- Hematology Reports, 2017, v. 9, n. 4, p. 128, doi. 10.4081/hr.2017.7201
- By:
- Publication type:
- Article
Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID‐19: The GIMEMA EMATO‐0321 study.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 1, p. 54, doi. 10.1111/bjh.18385
- By:
- Publication type:
- Article
COVID‐19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 559, doi. 10.1111/bjh.17890
- By:
- Publication type:
- Article
Assessment of droplet digital polymerase chain reaction for measuring BCR‐ABL1 in chronic myeloid leukaemia in an international interlaboratory study.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 53, doi. 10.1111/bjh.17521
- By:
- Publication type:
- Article
Next‐generation sequencing improves BCR‐ABL1 mutation detection in Philadelphia chromosome‐positive acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 2, p. 271, doi. 10.1111/bjh.17301
- By:
- Publication type:
- Article
Long‐term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high‐dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 1011, doi. 10.1111/bjh.16714
- By:
- Publication type:
- Article
Chronic myeloid leukaemia with extreme thrombocytosis at presentation: incidence, clinical findings and outcome.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 2, p. 267, doi. 10.1111/bjh.14553
- By:
- Publication type:
- Article
Safety and efficacy of <sup>90</sup> Yttrium- Ibritumomab- Tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.
- Published in:
- British Journal of Haematology, 2014, v. 164, n. 5, p. 710, doi. 10.1111/bjh.12695
- By:
- Publication type:
- Article
Gelatin/PLLA Sponge-Like Scaffolds Allow Proliferation and Osteogenic Differentiation of Human Mesenchymal Stromal Cells.
- Published in:
- Macromolecular Bioscience, 2008, v. 8, n. 9, p. 819, doi. 10.1002/mabi.200700331
- By:
- Publication type:
- Article
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- International Journal of Clinical Oncology, 2023, v. 28, n. 3, p. 363, doi. 10.1007/s10147-023-02295-0
- By:
- Publication type:
- Article
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Risk of progression in chronic phase‐chronic myeloid leukemia patients eligible for tyrosine kinase inhibitor discontinuation: Final analysis of the TFR‐PRO study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1762, doi. 10.1002/ajh.27073
- By:
- Publication type:
- Article
Flow Cytometric Immunobead Assay for Detection of BCR-ABL1 Fusion Proteins in Chronic Myleoid Leukemia: Comparison with FISH and PCR Techniques.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0130360
- By:
- Publication type:
- Article
JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.
- Published in:
- European Heart Journal, 2021, v. 42, n. 42, p. 4389, doi. 10.1093/eurheartj/ehab447
- By:
- Publication type:
- Article
The new Systematic Coronary Risk Evaluation (SCORE2 and SCORE2-OP) estimates the risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib or ponatinib.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 2, p. 427, doi. 10.1007/s00277-023-05556-0
- By:
- Publication type:
- Article
Efficacy and safety of nilotinib as frontline treatment in elderly (> 65 years) chronic myeloid leukemia patients outside clinical trials.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 6, p. 1375, doi. 10.1007/s00277-023-05159-9
- By:
- Publication type:
- Article
Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2005, doi. 10.1007/s00277-020-04392-w
- By:
- Publication type:
- Article
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- Annals of Hematology, 2019, v. 98, n. 8, p. 1885, doi. 10.1007/s00277-019-03705-y
- By:
- Publication type:
- Article
Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Pleural effusion and molecular response in dasatinib-treated chronic myeloid leukemia patients in a real-life Italian multicenter series.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Imaging studies in extramedullary hematopoiesis of the spleen.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Biological activity of lenalidomide in myelodysplastic syndromes with del5q: results of gene expression profiling from a multicenter phase II study.
- Published in:
- Annals of Hematology, 2013, v. 92, n. 1, p. 25, doi. 10.1007/s00277-012-1569-0
- By:
- Publication type:
- Article
Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients.
- Published in:
- 2011
- By:
- Publication type:
- Letter
Erratum to: pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients.
- Published in:
- 2011
- By:
- Publication type:
- Correction Notice
Carboxy‐terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA.
- Published in:
- Journal of Cellular Biochemistry, 2004, v. 93, n. 6, p. 1231, doi. 10.1002/jcb.20248
- By:
- Publication type:
- Article
Beyond BCMA, why GPRC5D could be the right way: treatment strategies with immunotherapy at relapse after anti-BCMA agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 12, p. 3931, doi. 10.1007/s00262-023-03559-4
- By:
- Publication type:
- Article